Travelport Worldwide (TVPT) Tops Q2 EPS by 10c
Get Alerts TVPT Hot Sheet
Join SI Premium – FREE
Travelport Worldwide (NYSE: TVPT) reported Q2 EPS of $0.40, $0.10 better than the analyst estimate of $0.30. Revenue for the quarter came in at $612.1 million versus the consensus estimate of $618.3 million.
Full Year 2017 Financial Guidance
The following forward-looking statements, as well as those made elsewhere within this press release, reflect expectations as of August 3, 2017. We assume no obligation to update these statements. Results may be materially different and are affected by many factors detailed in this release and in Travelport's quarterly and annual Securities and Exchange Commission ("SEC") filings and/or furnishings, which are available on the SEC's website at www.sec.gov.
Our guidance for full year 2017 net revenue is unchanged, as detailed below. Furthermore, we continue to anticipate that our commercial payments business, eNett, will grow net revenue by at least 20% in 2017. This is subject to exchange rate movements given that eNett's net revenue is largely denominated in currencies other than the U.S. dollar.
We continue to anticipate Adjusted EBITDA, Adjusted Net Income and Adjusted Income per Share (diluted) to be towards the higher end of our guidance ranges.
We now anticipate Free Cash Flow to be higher than the previously guided range, principally due to the phasing of capital and other expenditure.
FY 2017 Guidance | |||
(in $ millions, except per share amounts) | Revised | Growth | Previous |
Net revenue | $2,425 - $2,475 | 3% - 5% | Unchanged |
Adjusted EBITDA (1) | $585 - $595 | 2% - 4% | Unchanged |
Adjusted Net Income (1) | $165 - $175 | 7% - 13% | Unchanged |
Adjusted Income per Share – diluted (2) | $1.29 - $1.37 | 5% - 12% | Unchanged |
Free Cash Flow (3) | $190 - $210 | (1)% - 10% | $165 - $185 |
For earnings history and earnings-related data on Travelport Worldwide (TVPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Star Equity to acquire Harte Hanks for $5 per share in cash and stock
- Daré Bioscience prices $6M direct offering at $1.37 per share
- KKR prices secondary offering of 5 million BridgeBio shares
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share